Company Profile
Pulmatrix Stock Price, News & Analysis
- Ticker:
- PULM
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Pulmatrix is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.50 USD (-2.60%)
Close
Last updated: June 23, 2026 at 00:00
5.48M USD
Market cap
Why the stock is moving
PULM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Pulmatrix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Pulmatrix is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Pulmatrix follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Pulmatrix sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Pulmatrix Announces First Quarter 2026 Financial Results
Source: Pulmatrix
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pulmatrix (PULM)?
Pulmatrix (PULM) most recently closed at 1.50 USD, a -2.60% move versus the previous session.
What is the market cap of Pulmatrix (PULM)?
Pulmatrix currently has a market capitalization of 5.48M USD on BioPharmSignal.
What does Pulmatrix do?
Pulmatrix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is PULM stock listed?
Pulmatrix (PULM) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Pulmatrix is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Pulmatrix?
Pulmatrix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Pulmatrix targeting with Pulmatrix?
Pulmatrix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.